uric acid has been researched along with Dyspnea in 6 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-four symptomatic CHF participants with hyperuricemia (≥ 565 μmol/L) were randomized to receive prednisone (1 mg/kg/d, orally) or allopurinol (100 mg, thrice daily, orally) for 4 weeks." | 9.17 | Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study. ( Gao, Y; Ji, L; Ji, Z; Liu, C; Liu, G; Liu, K; Tian, L; Wang, L; Zhao, Q; Zhen, Y, 2013) |
| "We prospectively investigated the diagnostic and prognostic value of uric acid in 743 unselected patients presenting to the Emergency Department with acute dyspnea." | 7.75 | Diagnostic and prognostic value of uric acid in patients with acute dyspnea. ( Breidthardt, T; Burri, E; Christ, M; Hartwiger, S; Klima, T; Laule, K; Mebazaa, A; Mueller, C; Noveanu, M; Potocki, M; Reichlin, T; Stelzig, C, 2009) |
| "Thirty-four symptomatic CHF participants with hyperuricemia (≥ 565 μmol/L) were randomized to receive prednisone (1 mg/kg/d, orally) or allopurinol (100 mg, thrice daily, orally) for 4 weeks." | 5.17 | Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study. ( Gao, Y; Ji, L; Ji, Z; Liu, C; Liu, G; Liu, K; Tian, L; Wang, L; Zhao, Q; Zhen, Y, 2013) |
| "We prospectively investigated the diagnostic and prognostic value of uric acid in 743 unselected patients presenting to the Emergency Department with acute dyspnea." | 3.75 | Diagnostic and prognostic value of uric acid in patients with acute dyspnea. ( Breidthardt, T; Burri, E; Christ, M; Hartwiger, S; Klima, T; Laule, K; Mebazaa, A; Mueller, C; Noveanu, M; Potocki, M; Reichlin, T; Stelzig, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wattanachayakul, P | 1 |
| Rujirachun, P | 1 |
| Charoenngam, N | 1 |
| Ungprasert, P | 1 |
| Lee, H | 1 |
| Hong, Y | 1 |
| Lim, MN | 1 |
| Bak, SH | 1 |
| Kim, MJ | 1 |
| Kim, K | 1 |
| Kim, WJ | 1 |
| Park, HY | 1 |
| Reichlin, T | 1 |
| Potocki, M | 1 |
| Breidthardt, T | 1 |
| Noveanu, M | 1 |
| Hartwiger, S | 1 |
| Burri, E | 1 |
| Klima, T | 1 |
| Stelzig, C | 1 |
| Laule, K | 1 |
| Mebazaa, A | 1 |
| Christ, M | 1 |
| Mueller, C | 1 |
| Liu, C | 1 |
| Zhao, Q | 1 |
| Zhen, Y | 1 |
| Gao, Y | 1 |
| Tian, L | 1 |
| Wang, L | 1 |
| Ji, L | 1 |
| Liu, G | 1 |
| Ji, Z | 1 |
| Liu, K | 1 |
| Tong, TK | 1 |
| Fu, FH | 1 |
| Chow, BC | 1 |
| Quach, B | 1 |
| Lu, K | 1 |
| Friedman, GD | 1 |
| Siegelaub, AB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prednisone Versus Allopurinol for Symptomatic Heart Failure Patients With Hyperuricemia[NCT00919243] | Phase 4 | 40 participants (Anticipated) | Interventional | 2009-02-28 | Completed | ||
| Long-term Prednisone Use in Patients With Advanced Heart Failure (ACCF/AHA Stage D) and Hyperuricemia[NCT02282683] | Phase 2/Phase 3 | 90 participants (Anticipated) | Interventional | 2013-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for uric acid and Dyspnea
| Article | Year |
|---|---|
Chronic obstructive pulmonary disease (COPD) is associated with a higher level of serum uric acid. A systematic review and meta-analysis.
Topics: Biomarkers; Disease Progression; Dyspnea; Health Status; Humans; Pulmonary Disease, Chronic Obstruct | 2020 |
1 trial available for uric acid and Dyspnea
| Article | Year |
|---|---|
Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Topics: Adult; Allopurinol; Creatinine; Dyspnea; Female; Glomerular Filtration Rate; Glucocorticoids; Gout S | 2013 |
Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Topics: Adult; Allopurinol; Creatinine; Dyspnea; Female; Glomerular Filtration Rate; Glucocorticoids; Gout S | 2013 |
Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Topics: Adult; Allopurinol; Creatinine; Dyspnea; Female; Glomerular Filtration Rate; Glucocorticoids; Gout S | 2013 |
Prednisone in Uric Acid lowering in Symptomatic Heart Failure Patients With Hyperuricemia (PUSH-PATH) study.
Topics: Adult; Allopurinol; Creatinine; Dyspnea; Female; Glomerular Filtration Rate; Glucocorticoids; Gout S | 2013 |
4 other studies available for uric acid and Dyspnea
| Article | Year |
|---|---|
Inflammatory biomarkers and radiologic measurements in never-smokers with COPD: A cross-sectional study from the CODA cohort.
Topics: Aged; Bilirubin; C-Reactive Protein; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; | 2018 |
Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Diagnosis, Differential; Dyspnea; Female; Follow | 2009 |
Increased sensations of intensity of breathlessness impairs maintenance of intense intermittent exercise.
Topics: Adult; Ammonia; Dyspnea; Exercise; Humans; Male; Oxygen Consumption; Physical Endurance; Respiratory | 2003 |
Changes after quitting cigarette smoking.
Topics: Adult; Aged; Angina Pectoris; Blood Glucose; Blood Pressure; Cholesterol; Chronic Disease; Coronary | 1980 |